JP2024513087A5 - - Google Patents

Info

Publication number
JP2024513087A5
JP2024513087A5 JP2023561238A JP2023561238A JP2024513087A5 JP 2024513087 A5 JP2024513087 A5 JP 2024513087A5 JP 2023561238 A JP2023561238 A JP 2023561238A JP 2023561238 A JP2023561238 A JP 2023561238A JP 2024513087 A5 JP2024513087 A5 JP 2024513087A5
Authority
JP
Japan
Prior art keywords
dna
polynucleotide
cas
composition according
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023561238A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024513087A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/059070 external-priority patent/WO2022214522A2/en
Publication of JP2024513087A publication Critical patent/JP2024513087A/ja
Publication of JP2024513087A5 publication Critical patent/JP2024513087A5/ja
Pending legal-status Critical Current

Links

JP2023561238A 2021-04-07 2022-04-06 部位特異的改変のための組成物及び方法 Pending JP2024513087A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163171651P 2021-04-07 2021-04-07
US63/171,651 2021-04-07
US202163292144P 2021-12-21 2021-12-21
US63/292,144 2021-12-21
PCT/EP2022/059070 WO2022214522A2 (en) 2021-04-07 2022-04-06 Compositions and methods for site-specific modification

Publications (2)

Publication Number Publication Date
JP2024513087A JP2024513087A (ja) 2024-03-21
JP2024513087A5 true JP2024513087A5 (https=) 2025-04-15

Family

ID=81603442

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023561238A Pending JP2024513087A (ja) 2021-04-07 2022-04-06 部位特異的改変のための組成物及び方法

Country Status (4)

Country Link
US (1) US20240182890A1 (https=)
EP (1) EP4320234A2 (https=)
JP (1) JP2024513087A (https=)
WO (1) WO2022214522A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4133069A2 (en) * 2020-04-08 2023-02-15 Astrazeneca AB Compositions and methods for improved site-specific modification
CN121002177A (zh) * 2023-03-10 2025-11-21 先正达农作物保护股份公司 用于位点特异性整合的cas融合蛋白和相关方法
WO2025035110A1 (en) * 2023-08-10 2025-02-13 Linearx, Inc. Compositions and methods for in vitro transcription
WO2026083309A1 (en) 2024-10-17 2026-04-23 Astrazeneca Ab Use of inhibitors or modulators of artemis in gene editing

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543158A (en) 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
US6007845A (en) 1994-07-22 1999-12-28 Massachusetts Institute Of Technology Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
US5855913A (en) 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5895309A (en) 1998-02-09 1999-04-20 Spector; Donald Collapsible hula-hoop
SE0201863D0 (en) 2002-06-18 2002-06-18 Cepep Ab Cell penetrating peptides
JP2008078613A (ja) 2006-08-24 2008-04-03 Rohm Co Ltd 窒化物半導体の製造方法及び窒化物半導体素子
EP3269395A1 (en) 2008-11-07 2018-01-17 Massachusetts Institute Of Technology Aminoalcohol lipidoids and uses thereof
US9193827B2 (en) 2010-08-26 2015-11-24 Massachusetts Institute Of Technology Poly(beta-amino alcohols), their preparation, and uses thereof
EP2691443B1 (en) 2011-03-28 2021-02-17 Massachusetts Institute of Technology Conjugated lipomers and uses thereof
AU2013266968B2 (en) 2012-05-25 2017-06-29 Emmanuelle CHARPENTIER Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
DK2931891T3 (da) 2012-12-17 2019-08-19 Harvard College Rna-styret modificering af menneskelige genomer
CA2910802A1 (en) 2013-04-12 2014-10-16 Samir El Andaloussi Therapeutic delivery vesicles
US9650617B2 (en) 2015-01-28 2017-05-16 Pioneer Hi-Bred International. Inc. CRISPR hybrid DNA/RNA polynucleotides and methods of use
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
EP3443088B1 (en) * 2016-04-13 2024-09-18 Editas Medicine, Inc. Grna fusion molecules, gene editing systems, and methods of use thereof
GB201609216D0 (en) 2016-05-25 2016-07-06 Evox Therapeutics And Isis Innovation Ltd Exosomes comprising therapeutic polypeptides
WO2018094356A2 (en) * 2016-11-18 2018-05-24 Genedit Inc. Compositions and methods for target nucleic acid modification
CA3052099A1 (en) * 2017-01-30 2018-08-02 Mathias LABS Repair template linkage to endonucleases for genome engineering
EP3679143A1 (en) * 2017-09-08 2020-07-15 Life Technologies Corporation Methods for improved homologous recombination and compositions thereof
US11649442B2 (en) * 2017-09-08 2023-05-16 The Regents Of The University Of California RNA-guided endonuclease fusion polypeptides and methods of use thereof
CN120310773A (zh) 2017-11-16 2025-07-15 阿斯利康(瑞典)有限公司 用于改善基于Cas9的敲入策略的有效性的组合物和方法
EP3781677A4 (en) * 2018-04-16 2022-01-19 University of Massachusetts COMPOSITIONS AND METHODS FOR IMPROVED GENE EDITTING
CN113825834A (zh) * 2019-03-11 2021-12-21 索伦托药业有限公司 使用rna引导的核酸内切酶进行dna构建体整合的改进工艺
WO2020191233A1 (en) * 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
WO2021034373A1 (en) * 2019-08-19 2021-02-25 Minghong Zhong Conjugates of guide rna-cas protein complex
US20210079387A1 (en) * 2019-08-27 2021-03-18 The Jackson Laboratory Cleavage-resistant donor nucleic acids and methods of use

Similar Documents

Publication Publication Date Title
JP2024513087A5 (https=)
AU2020262371B2 (en) Nucleic acid constructs and methods for their manufacture
JP7038079B2 (ja) Ｃｒｉｓｐｒハイブリッドｄｎａ／ｒｎａポリヌクレオチドおよび使用方法
ES2762866T3 (es) Reemplazo de nucleótidos por bibliotecas doblemente etiquetadas y direccionales
JP2022078083A (ja) 化学修飾を有するガイドｒｎａ
JP2025098047A (ja) 非天然ヌクレオチドの組み込み及びその方法
US20230357790A1 (en) Self-targeting expression vector
JP2022521787A5 (https=)
EP4737574A2 (en) Poly-tailed and poly-capped mrna and uses thereof
CN117957317A (zh) 用于先导编辑的具有化学修饰的指导rna
EP4509608A1 (en) Capped rna and method for producing same, apparatus for producing protein, and method for producing protein
TW202227100A (zh) 包含非天然核苷酸之多核苷酸之反轉錄
CN114981445A (zh) 修饰的双链供体模板
US11761033B2 (en) Methods to amplify highly uniform and less error prone nucleic acid libraries
EP3638810A1 (en) Methods of library construction for target polynucleotides
CN108473985A (zh) 用于减少接头-二聚体形成的方法和试剂盒
Balke et al. In vitro repair of a defective EGFP transcript and translation into a functional protein
Kataoka et al. Highly efficient enzymatic synthesis of 3′-deoxyapionucleic acid (apioNA) having the four natural nucleobases
WO2025170909A1 (en) Nucleic acids with region-specific modifications and methods of making the same
Kalidas et al. Nucleosides and Nucleotides
CN118019858A (zh) 用于核酸测序的预文库靶标富集
Figazzolo Synthesis and biochemical characterization of novel moieties to be incorporated in aptamers
WO2026057749A1 (en) Method and product
Sasnauskas et al. Template-directed addition of nucleosides to DNA by the BfiI restriction enzyme
AU2022407332A1 (en) A method of capturing crispr endonuclease cleavage products